In 2023, Samsung Biologics posted a sales revenue of around 3.7 trillion South Korean won, with a steady increase since 2015. Samsung Biologics is a pharmaceutical company of Samsung Group and produces biopharmaceuticals for global companies. Biotech and health sector are among the key growth engine industries of Samsung Group.
Sales revenue of Samsung Biologics from 2015 to 2023
(in billion South Korean won)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
DART. (March 7, 2024). Sales revenue of Samsung Biologics from 2015 to 2023 (in billion South Korean won) [Graph]. In Statista. Retrieved October 02, 2024, from https://www.statista.com/statistics/1165961/samsung-biologics-sales-revenue/
DART. "Sales revenue of Samsung Biologics from 2015 to 2023 (in billion South Korean won)." Chart. March 7, 2024. Statista. Accessed October 02, 2024. https://www.statista.com/statistics/1165961/samsung-biologics-sales-revenue/
DART. (2024). Sales revenue of Samsung Biologics from 2015 to 2023 (in billion South Korean won). Statista. Statista Inc.. Accessed: October 02, 2024. https://www.statista.com/statistics/1165961/samsung-biologics-sales-revenue/
DART. "Sales Revenue of Samsung Biologics from 2015 to 2023 (in Billion South Korean Won)." Statista, Statista Inc., 7 Mar 2024, https://www.statista.com/statistics/1165961/samsung-biologics-sales-revenue/
DART, Sales revenue of Samsung Biologics from 2015 to 2023 (in billion South Korean won) Statista, https://www.statista.com/statistics/1165961/samsung-biologics-sales-revenue/ (last visited October 02, 2024)
Sales revenue of Samsung Biologics from 2015 to 2023 (in billion South Korean won) [Graph], DART, March 7, 2024. [Online]. Available: https://www.statista.com/statistics/1165961/samsung-biologics-sales-revenue/